Publications



Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial.
J Clin Lipidol 2018 Jan - Feb;12(1):173-184. Epub 2017 Oct 28.
Department of Community Medicine and Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan; Department of Cardiovascular Medicine, Rinku General Medical Center, Izumisano, Japan.


Self-reported quality of sleep is associated with physical strength among community-dwelling young-old adults.
Geriatr Gerontol Int 2017 Nov 6;17(11):1808-1813. Epub 2017 Jan 6.
Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.



Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study.
BMJ Open 2017 Jul 2;7(6):e014427. Epub 2017 Jul 2.
Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute, Osaka, Japan.







Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial.
Atherosclerosis 2016 Jun 26;249:36-43. Epub 2016 Feb 26.
Laboratory for Systems Biology and Medicine (LSBM), Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo, 153-8904, Japan. Electronic address:





AMAP1 as a negative-feedback regulator of nuclear factor-κB under inflammatory conditions.
Sci Rep 2014 May 28;4:5094. Epub 2014 May 28.
1] Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan [2] Department of Clinical Innovative Medicine, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.


Priorities of health care outcomes for the elderly.
J Am Med Dir Assoc 2013 Jul 14;14(7):479-84. Epub 2013 Feb 14.
Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan.
J Atheroscler Thromb 2012 25;19(11):1019-26. Epub 2012 Oct 25.
Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.

Chronic kidney disease (CKD) is an independent risk factor for long-term care insurance (LTCI) need certification among older Japanese adults: a two-year prospective cohort study.
Arch Gerontol Geriatr 2013 Nov-Dec;57(3):328-32. Epub 2013 Apr 6.
Department of Human Health Sciences, Kyoto University Graduate School of Medicine, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.






OF